Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

[Breast implants and cancer: Anaplastic large cell lymphoma in breast implants].

PMID: 41620260 · 2026

JournalAnnales de chirurgie plastique et esthetique
Year2026
PMID41620260

Abstract

This article aims to provide recommendations on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), caused by textured breast implants. These recommendations are based on both updated data from the literature and the experience gained in the management and treatment of patients by the French-speaking Adult Lymphoma Study Group, Lymphoma Study Association (LYSA), regarding BIA-ALCL. Studies indexed in PubMed, focusing on breast surgery and breast implant-associated lymphoma, publ

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.